bioMérieux S.A.
$81.68-2.76%($-2.32)
TickerSpark Score
64/100
84
Valuation
85
Profitability
25
Growth
96
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMXMF research report →
52-Week Range6% of range
Low $77.38
Current $81.68
High $152.00
Companywww.biomerieux.com
bioMérieux S. A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
- CEO
- Pierre Boulud
- IPO
- 2017
- Employees
- 14,147
- HQ
- Marcy l'Étoile, FR
Price Chart
-37.04% · this period
Valuation
- Market Cap
- $9.64B
- P/E
- 21.54
- P/S
- 2.11
- P/B
- 2.09
- EV/EBITDA
- 8.89
- Div Yield
- 1.24%
Profitability
- Gross Margin
- 53.07%
- Op Margin
- 9.54%
- Net Margin
- 9.76%
- ROE
- 9.89%
- ROIC
- 6.32%
Growth & Income
- Revenue
- $4.07B · 2.22%
- Net Income
- $397.35M · -8.06%
- EPS
- $3.37 · -8.17%
- Op Income
- $560.99M
- FCF YoY
- 40.85%
Performance & Tape
- 52W High
- $152.00
- 52W Low
- $77.38
- 50D MA
- $98.69
- 200D MA
- $120.86
- Beta
- 0.54
- Avg Volume
- 64
Get TickerSpark's AI analysis on BMXMF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BMXMF Coverage
We haven't published any research on BMXMF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BMXMF Report →Similar Companies
MYNZ-5.07%
Mainz Biomed B.V.
$0.70
APDN+31.62%
Applied DNA Sciences, Inc.
$5.62
STIM+0.85%
Neuronetics, Inc.
$1.19
PRE+5.85%
Prenetics Global Limited
$15.47
FONR+0.16%
FONAR Corporation
$18.89
IQV-0.97%
IQVIA Holdings Inc.
$171.50
MTD+3.04%
Mettler-Toledo International Inc.
$1082.67
TWST+8.40%
Twist Bioscience Corporation
$53.66